HPHelena de Souza Pereira

Helena de Souza Pereira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Helena de Souza Pereira has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trajetória acadêmica e atuação profissional: um estudo com egressos do curso de licenciatura em Ciências Biológicas de uma universidade pública

    by Helena de Souza Pereira, Priscilla Oliveira Silva Bomfim, Julia de Lacerda Ruiz, Luiz Roberto Leão-Ferreira

    Resumo A compreensão da percepção dos egressos de um curso de graduação é importante para avaliar a qualidade da formação acadêmica e aprimorar os processos formativos. Este estudo resultou de uma análise descritiva da percepção dos egressos do curso de Licenciatura em Ciências Biológicas de uma universidade pública brasileira sobre a formação acadêmica, a preparação para a atuação docente e a inserção desses profissionais no mercado de trabalho. Foram utilizados dados institucionais referentes à população de egressos formados pelo currículo vigente, bem como informações coletadas por meio de um questionário online aplicado a uma amostra desse grupo. Os resultados revelaram um amplo engajamento dos egressos em atividades de ensino, pesquisa e extensão durante a graduação. A pesquisa também abordou as perspectivas desses indivíduos em relação à pós-graduação, os desafios para o ingresso e manutenção na carreira docente e coletou críticas e sugestões sobre o currículo do curso.

  • Open Access

    Egressos do curso de Medicina Veterinária da UFF: situação profissional atual e opiniões acerca da formação acadêmica

    by Helena de Souza Pereira, Luiza Carneiro Mareti Valente, Isabelle Marins Magalhães Trezze, Luiz Roberto Leão-Ferreira

    Os cursos de Medicina Veterinária, têm atualizado regularmente seus currículos de modo a atender às demandas da sociedade e da legislação vigente. No entanto, um levantamento de dados sobre a situação profissional dos egressos e suas opiniões sobre a formação acadêmica recebida, podem contribuir significativamente para esse processo. Nesse sentido, informações sobre uma população de egressos do curso de Veterinária da UFF foram coletadas a partir do banco de dados da instituição. Além disso, uma amostra dessa população foi consultada, por meio de questionário online. Os resultados obtidos nessas duas abordagens permitiram conhecer o perfil sociodemográfico da população, bem como o perfil socioeconômico e profissional da amostra, além de suas opiniões a respeito da experiência acadêmica.


  • A neuroscience board game as a tool to discuss mechanisms of drug abuse and addiction issues in the classroom

    by Luana Da Silva Chagas, Sarah Chagas De Almeida Silva, Rafaela Matos Coelho De Oliveira, Thaís Magalhães Manhães, Giovanna Vicenta De Oliveira Braga, Beatriz Sarmiero Rodolpho, Helena De Souza Pereira, Priscilla Oliveira Silva Bomfim

    Discussing substance abuse, licit or not, requires dynamism when it comes to adolescents. Games are a powerful tool to bring the subject up for discussion. Here we describe a collaborative board game designed to address this subject using current neuroscience knowledge about neurophysiology of (drug) addiction. The game highlights the action of 22 neuroactive drugs, classified into the following groups: (1) depressants; (2) hallucinogens; (3) stimulants and (4) others (anabolic steroids and prescription drugs). In addition, the game was developed to approach specific neuroscience-related themes such as: (1) brain structures (e.g. lobes); (2) cell types present in the nervous system; (3) neurotransmitter actions; (4) impact of drug abuse on the nervous system function; (5) the concept of overdose. Moreover, the game has got an educational proposal that combines the individual and social aspects of development, addressing concepts of neurosciences in a playful and stimulating way, aiming to promote not only awareness regarding the abuse of chemical substances, but also to stimulate the social development of the participants at the same time. It is worth mentioning that drug cards also bring curiosities and cultural trivia, including music and art, making it more attractive for young audiences.


  • Novel 4‐arylaminoquinoline‐3‐carbonitriles as Inhibitors of HIV‐1 Reverse Transcriptase

    by Beatriz C. L. Melo, Alice M. R. Bernardino, Gustavo Polillo, Helena S. Pereira, Izabel C. P. Paixão, Michele S. Ribeiro, Julio C. Borges

    This paper describes the synthesis of several new 4‐arylaminoquinoline‐3‐carbonitriles derivatives. These were evaluated on the activity reverse transcriptase (RT) of HIV‐1. Most of the synthesized compounds showed significant in vitro inhibition of RT enzyme, especially derivative 3h (IC50 = <8 μM). The derivatives showed low‐level cytotoxicity.


  • Pseudo-peptides derived from isomannide: inhibitors of serine proteases

    by Thalita G. Barros, Sergio Pinheiro, J. S. Williamson, Amílcar Tanuri, M. Gomes, Helena S. Pereira, R. M. Brindeiro, José B. A. Neto, O. A. C. Antunes, Estela M. F. Muri

    In this paper, we describe the synthesis of a novel class of pseudo-peptides derived from isomannide and several oxazolones as potential inhibitors of serine proteases as well as preliminary pharmacological assays for hepatitis C. Hepatitis C, dengue and West Nile fever are among the most important flaviviruses that share one important serine protease enzyme. Serine proteases belong to the most studied class of proteolytic enzymes and are a primary target in the drug development field. Several pseudo-peptides were obtained in good yields from the reaction of isomannide and oxazolones, and their anti-HCV potential using the HCV replicon-based assay was shown.


  • Enfuvirtide (T-20) Resistance-Related Mutations in HIV Type 1 Subtypes B, C, and F Isolates from Brazilian Patients Failing HAART

    by A.C.A. Oliveira, A.N. Martins, A.F.N.P.C. Pires, M.B. Arruda, A. Tanuri, H.S. Pereira, R.M. Brindeiro

    The synthetic peptide T-20 (enfuvirtide, EFV) represents the first compound approved by the FDA known as entry inhibitors (EIs). The resistance mutations associated with this new class of antiretroviral drug are located in the first heptad repeat (HR1) region of gp41. Amino acid changes in codons G36D/S, I37V, V38A/M/E, Q39H/R, Q40H, N42T, and N43D can confer resistance to EFV. In this work we investigated the presence of resistance mutations that occur in patients never treated with EFV and failing HAART with protease inhibitors (PIs), nucleoside reverse transcriptase (RT) inhibitors (NRTIs), and nonnucleoside RT inhibitors (NNRTIs). This knowledge can reveal whether this salvage therapy can be effective in patients failing HAART. For this, we amplified 65 samples from plasma isolates and than sequenced a fragment of 416 nt encompassing the HR1 and HR2 regions (amino acids 33-170 of gp41). The subtype distribution among the 65 isolates was 45 (69.23%) subtype B, 9 (13.85%) subtype C, 7 (10.77%) subtype F1, and 4 (6.15%) mosaics B/F1, B/C, F1/C, and C/F1/B. We found a high prevalence (7.6%) of EFV-associated mutation G36D in this cohort of patients failing HAART therapy, five isolates from subtype B (11.11% within this group). In contrast, when 1079 sequences from drug-naive patients were analyzed, only one showed the G36D substitution. This finding indicates a strong association between the selected position G36D and HAART therapy (p < 0.0001). The isolates that possess these mutations can develop resistance to EFV more rapidly. Nevertheless, more information about the impact of these mutations in salvage therapy with EFV in patients failing HAART must still be obtained.


  • Novel Peptide Mimetic Inhibitors of Hepatitis C Serine Protease Derived from Isomannide

    by Estela Muri, Thalita Barros, Sergio Pinheiro, John Williamson, Amílcar Tanuri, Helena Pereira, Rodrigo Brindeiro, José Neto, Octávio Antunes

    Hepatitis C (HCV) infection is a cause of chronic liver disease such as cirrhosis, carcinoma, or liver failure, and the current therapy is effective in only 50% of patients. Serine proteases, which are present in HCV, are the most studied class of proteolytic enzymes­, and are a primary target in the drug development field. In this paper, we describe the synthesis and biological studies of a novel­ class of peptide mimetic compounds as potential HCV serine protease inhibitors.


  • Development of a New Methodology for Screening of Human Immunodeficiency Virus Type 1 Microbicides Based on Real-Time PCR Quantification

    by Renato S. Aguiar, Luciana J. Costa, Helena S. Pereira, Rodrigo M. Brindeiro, Amilcar Tanuri

    Potential topical retrovirucides or vaginal microbicides against human immunodeficiency virus type 1 (HIV-1) include nonnucleoside reverse transcriptase inhibitors (NNRTIs). To be successful, such agents have to be highly active against cell-free virions. In the present study, we developed a new real-time PCR-based assay to measure the natural endogenous reverse transcription (NERT) activity directly on intact HIV-1 particles in the presence of reverse transcriptase (RT) inhibitors. We further evaluated the permeability to nevirapine (NVP) and efavirenz (EFV) and their retention within nascent viral particles. We also demonstrated the NVP and EFV inhibitory effects on NERT activity and the impact of resistance mutations measured directly by this new strategy. Furthermore, the results showed a clear correlation between NERT activity and classical infectivity assays. The 50% inhibitory concentrations (IC50s) of NVP and EFV were demonstrated to be up to 100-fold higher for cell-free than for cell-associated virions, suggesting that cell-free virions are less permeable to these drugs. Our results suggest that NVP and EFV penetrate both the envelope and the capsid of HIV-1 particles and readily inactivate cell-free virions. However, the characteristics of these NNRTIs, such as lower permeability and lower retention during washing procedures, in cell-free virions reduce their efficacies as microbicides. Here, we demonstrate the usefulness of the NERT real-time PCR as an assay for screening novel antiretroviral compounds with unique mechanisms of action.


  • Open Access

    Gag–Pol bearing a reverse transcriptase drug-resistant mutation influences viral genomic RNA incorporation into human immunodeficiency virus type 1 particles

    by Renato S. Aguiar, Helena S. Pereira, Luciana J. Costa, Rodrigo M. Brindeiro, Amilcar Tanuri

    The unspliced human immunodeficiency virus type 1 (HIV-1) RNA is both the messenger for Gag and Gag–Pol and the viral genomic RNA (vRNA) that is packaged into the virion. Although Gag alone is sufficient for the incorporation of vRNA into virus particles, Gag–Pol molecules play an important role in vRNA dimerization and virion maturation. Here, a cis model for vRNA packaging was demonstrated, in which nascent Gag–Pol molecules were preferentially co-encapsulated with their cognate RNA used as the template. Genome-incorporation frequencies were evaluated for two distinct HIV-1 proviral clones differing in their ability to respond to nevirapine (NVP) treatment in one round of infection. It was shown that, under NVP selection, there was a twofold-higher incorporation of vRNAs and integration of provirus genome carrying NVP resistance when compared with the wild-type counterpart. Although cis incorporation has been already demonstrated for Gag, the novelty of these findings is that newly acquired resistant mutations in Gag–Pol will select their specific genomic RNA during virus replication, thus rapidly increasing the chance of the emergence of resistant viruses during the course of anti-retroviral treatment.


  • Effects of Diterpenes Isolated from the Brazilian Marine AlgaDictyota menstrualison HIV-1 Reverse Transcriptase

    by Helena de Souza Pereira, Luiz Roberto Leão-Ferreira, Nissin Moussatché, Valéria Laneuville Teixeira, Diana Negrão Cavalcanti, Luciana Jesus da Costa, Ricardo Diaz, Izabel Christina de Palmer Paixão Frugulhetti

    It has been recently demonstrated that HIV-1 reverse transcriptase is the target of two diterpenes, (6R)-6-hydroxydichotoma-3,14-diene-1,17-dial (compound 1) and (6R)-6-acetoxydichotoma-3,14-diene-1,17-dial (compound 2), that inhibit HIV-1 replication in vitro. In this work, the effects of both diterpenes on the kinetic properties of the recombinant HIV-1 reverse transcriptase (RT) enzyme were evaluated. RNA-dependent DNA-polymerase (RDDP) activity assays demonstrated that both diterpenes behave as non-competitive inhibitors with respect to dTTP and uncompetitive inhibitors with respect to poly(rA)·oligo(dT) template primers. The K i values obtained for compounds 1 and 2 were 10 and 35 μM, respectively. Neither of these diterpenes affected the DNA-dependent DNA-polymerase (DDDP) activity of the HIV-1 RT. The RDDP activities of AMV-RT and MMLV-RT enzymes were also inhibited by compounds 1 and 2. In contrast to the HIV-1 enzyme, the DDDP activities of AMV-RT and MMLV-RT enzymes were significantly reduced by compound 1. Taken together, our results demonstrate that compound 1 is a more effective inhibitor of the viral reverse transcriptases from HIV-1, AMV and MMLV than compound 2. The kinetic behavior analyses of the HIV-1 RT demonstrate that both diterpenes have similar mechanisms of inhibition of RDDP activity. Compound 1:(6R)-6-hydroxydichotoma-3,14-diene-1,17-dial Compound 2:(6R)-6-acetoxydichotoma-3,14-diene-1,17-dial HIV-1 RT:human immunodeficiency virus type-1 reversetranscriptase AMV:avian myeloblastosis virus MMLV:Moloney murine leukemia virus